Immatics NV (IMTX)
10.81
-0.27
(-2.44%)
USD |
NASDAQ |
May 16, 16:00
10.82
+0.01
(+0.09%)
After-Hours: 20:00
Immatics Cash from Investing (TTM): -292.65M for March 31, 2024
Cash from Investing (TTM) Chart
Historical Cash from Investing (TTM) Data
| Date | Value |
|---|---|
| March 31, 2024 | -292.65M |
| December 31, 2023 | -33.98M |
| September 30, 2023 | -199.99M |
| June 30, 2023 | -191.97M |
| March 31, 2023 | -231.79M |
| December 31, 2022 | -221.24M |
| September 30, 2022 | -122.59M |
| Date | Value |
|---|---|
| June 30, 2022 | -30.40M |
| March 31, 2022 | 12.33M |
| December 31, 2021 | 8.866M |
| September 30, 2021 | 10.96M |
| June 30, 2021 | -43.27M |
| March 31, 2021 | 6.083M |
| December 31, 2020 | -18.21M |
Cash From Investing Definition
Cash from Investing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall investing activities of the company. A few examples of investing activities include net change in PP&E, and net divestitures.
Cash from Investing (TTM) Range, Past 5 Years
-292.65M
Minimum
Mar 2024
12.33M
Maximum
Mar 2022
-96.28M
Average
-38.62M
Median
Cash from Investing (TTM) Benchmarks
| MorphoSys AG | -- |
| Affimed NV | -39.04M |
| InflaRx NV | 13.96M |
| BioNTech SE | -9.242B |
| CureVac NV | -59.76M |